Nadiyah Ali
About Nadiyah Ali
Nadiyah Ali is an Associate Pharmacovigilance Scientist currently working at Deciphera Pharmaceuticals. She has a background in pharmacovigilance and pharmacy, having previously held roles at Karyopharm Therapeutics Inc. and completed her education at Northeastern University.
Current Role at Deciphera Pharmaceuticals
Nadiyah Ali serves as an Associate Pharmacovigilance Scientist at Deciphera Pharmaceuticals. She has held this position since 2022, contributing to the company's efforts in drug safety and monitoring. Her role involves analyzing data related to adverse drug reactions and ensuring compliance with regulatory requirements. Deciphera Pharmaceuticals is located in Waltham, Massachusetts, where Ali applies her expertise in pharmacovigilance to support the development of innovative therapies.
Previous Experience at Karyopharm Therapeutics Inc.
Prior to her current role, Nadiyah Ali worked at Karyopharm Therapeutics Inc. in various capacities. She started as a Pharmacovigilance Intern from 2019 to 2020, where she gained foundational experience in drug safety. She then progressed to the role of Pharmacovigilance Associate from 2020 to 2021, followed by a position as Pharmacovigilance Specialist from 2021 to 2022. During her time at Karyopharm, she focused on monitoring and reporting adverse events, contributing to the overall safety profile of the company's products.
Internship Experience in Pharmacy
Nadiyah Ali has completed several internships in pharmacy, which have contributed to her professional development. She interned at Spaulding Hospital Cambridge, Inc. in 2015 for three months, where she gained practical experience in a clinical setting. In 2019, she furthered her experience by interning at Massachusetts General Hospital for three months. These internships provided her with valuable insights into pharmacy operations and patient care.
Educational Background in Pharmacy
Nadiyah Ali holds a Doctorate in Pharmacy (PharmD) from Northeastern University, which she completed in 2019. Prior to her doctorate, she earned a Bachelor of Science in Pharmacy from the same institution, graduating in 2018. Her education at Northeastern University equipped her with a comprehensive understanding of pharmaceutical sciences, preparing her for a career in pharmacovigilance and drug safety.